The Future of Marketing: Key Trends You Need to Understand in 2021 (and beyond)
Marketing and customer engagement strategies experienced a major disruption in 2020. Brands and organizations were forced to launch, replace, or quickly evolve their strategies over the past year to keep pace with the combination of technology, market, and economic forces in play. What’s ahead for health and pharma marketing? What marketing trends matter? Which trends are hype? What emerging trends will change marketing the most in five years?Marketing and customer engagement strategies experienced a major disruption in 2020. Brands and organizations were forced to launch, replace, or quickly evolve their strategies over the past year to keep pace with the combination of technology, market, and economic forces in play. What’s ahead for health and pharma marketing? What marketing trends matter? Which trends are hype? What emerging trends will change marketing the most in five years?
Session Chair(s)
Dale Cooke, JD, MA
President
PhillyCooke Consulting , United States
Dale Cooke is president of PhillyCooke Consulting, which helps prescription product marketers use 21st century technology to provide healthcare information while ensuring compliance with FDA regulations written in the 1960s. Dale is the author of Effective Review & Approval of Digital Promotional Tactics, now in its second edition, which was published by the Food & Drug Law Institute.
Mark Bard, MBA, MHA
Founder
Digital Health Coalition, United States
Mark Bard is a new media, marketing, and technology entrepreneur. In addition to personal ventures, he invests in technology and health startups taking an active advisory role with founders. Mark’s focus and passion includes digital, data analytics, and customer service in a connected world. Mark co-founded the Digital Health Coalition, a non-profit think tank based in New York, in 2011. Mark previously sold Manhattan Research, a company he co-founded, to Providence Equity Partners.
Speaker(s)
R.J. Lewis, MBA
Founder, President, & CEO
eHealthcare Solutions, United States
R.J. Lewis is Founder and CEO of eHealthcare Solutions (EHS). eHealthcare Solutions delivers audiences and drives digital innovation for both advertisers and publishers. EHS exclusively represents 85 high-quality healthcare publishers. The EHS vision is to aggregate niche audiences for the measurable benefit of both marketers and publishers. EHS has been named a PM360 Trailblazer Company of the Year and Mr. Lewis has been named to the PharmaVOICE 100 list of most inspiring leaders in life sciences. R.J. is a parallel entrepreneur having started Ad-Juster and Tap Native while running eHealthcare Solutions. R.J. earned his MBA in 1999 in Marketing and Information Systems from NYU. Reach R.J. at rlewis@ehsmail.com or on Twitter @rlewis
David Bernstein
Chief Revenue Officer
Everyday Health Group Consumer, United States
David Bernstein serves as the Chief Revenue Officer and SVP of Sales and Strategic Partnerships for Everyday Health Consumer. David has dedicated his 20-year plus career to improving the outcomes of the “patient journey” for all key stakeholders. Prior to joining the Everyday Health Group, David was the Executive Vice President, Head of Sales at Outcome Health, a point-of-care technology and media platform for waiting rooms, exam rooms, and infusion rooms. Previously, David held the roles of Vice President of Business Development at ConnectiveRx partnering with biopharmaceutical manufacturers. Earlier in his career, David spent almost a decade with the global pharmaceutical company GlaxoSmithKline as a Senior Product Manager.
Melinda Decker, MBA, MS
Chief Commercial Officer
Mymee, United States
Melinda Decker is Chief Commercial Officer of Mymee, the leading digital health company that empowers those who suffer from autoimmune disease to reclaim their health. Mymee combines an intuitive mobile app, data analytics, and certified health coaches to help identify triggers for disease symptoms to improve quality of life. Melinda also serves as an advisor to MIT’s Health Science & Technology program and to several companies focused on digital health. She previously worked at AstraZeneca and Pfizer, spanning commercial and R&D.